J44
Conditions
Interventions
Group 1: In a period from 10/23 to probably 01/25, patients who are treated either as inpatients or outpatients at the Cologne-Merheim Lung Clinic (KdSK) and suffer from COPD GOLD II-IV will be examin
Sponsors
Krankenhaus Köln-Merheim
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Previously known or newly diagnosed COPD according to the definition of obstruction according to the bronchospasmolysis test Z value < -1.64 - Smoker/ex-smoker with at least 20 pack-years - Consent to data protection and patient information - Willingness to answer the questionnaires in full - Linguistic and cognitive abilities to answer the questionnaires
Exclusion criteria
Exclusion criteria: - Patient age 300/microliter - Alpha-1-antitrypsin deficiency - FENO values > 40 ppm - Pre-existing conditions (asthma, bronchiectasis, ILD, bronchial CA, other pneumological diseases)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Validation/falsification of the hypothesis: Dyspnea is heterogeneous What causes dyspnoea in COPD? - Classify dyspnoea as a general symptom | — |
Secondary
| Measure | Time frame |
|---|---|
| Validation/falsification of the hypotheses: 1. identification of the predictors for the individual dyspnea qualities based on the diagnostics performed 2. differences in the severity of dyspnoea between the identified COPD types 3. differences in the frequency of exacerbations between the COPD types characterized by different dyspnoea qualities 4. do hyperinflated patients have impaired diaphragmatic function? | — |
Countries
Germany
Contacts
Public ContactMaximilian Zimmermann
Krankenhaus Köln-Merheim
Outcome results
None listed